mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.8 |
mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
-0.0095 |
0.8 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
UNC1215 |
GDSC1000 |
pan-cancer |
AAC |
0.0072 |
0.8 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.8 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |